Title 21: Food and Drugs
« Home / Title 21 - Food and Drugs--Volume 6 / CHAPTER I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) / SUBCHAPTER E - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS
/ PART 556 - TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD / Subpart B - Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs / § 556.226 Enrofloxacin.
§ 556.226 Enrofloxacin.
(a) Acceptable daily intake (ADI). The ADI for total residue of enrofloxacin is 3 µg/kg of body weight per day.
(b) Tolerances. The tolerances for enrofloxacin are:
(1) Cattle. Liver (target tissue): 0.1 ppm desethylene ciprofloxacin (marker residue).
(2) Swine. Liver (target tissue): 0.5 ppm enrofloxacin (marker residue).
(c) Related conditions of use. See § 522.812 of this chapter.